Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations

D. W. M. Verhagen, A. C. Vedder, P. Speelman, J. T. M. van der Meer

Research output: Contribution to journalReview articleAcademicpeer-review


In this article we present the path that led to current concepts regarding antimicrobial treatment of endocarditis caused by viridans streptococci highly susceptible to penicillin. Early treatment trials indicate that some patients with subacute endocarditis can be cured with shorter treatment duration than currently advised by international guidelines. Also, high-dose antibiotics, as recommended today, have a predominantly pharmacokinetic and pharmacodynamic rationale that is based mostly on experimental animal studies. Shortening antimicrobial treatment in select patients with endocarditis would be of great benefit. As yet there are no predictors of cure that can be used to individualize treatment duration in patients with bacterial endocarditis
Original languageEnglish
Pages (from-to)819-824
JournalJournal of antimicrobial chemotherapy
Issue number5
Publication statusPublished - 2006

Cite this